Neurology Minute
Oral Rimegepant in Adults With Migraine and Cardiovascular Risk Factors
- Author: Vários
- Narrator: Vários
- Publisher: Podcast
- Duration: 0:03:40
- More information
Informações:
Synopsis
Dr. Susan Hutchinson discusses her abstract, "Oral Rimegepant 75 mg is Safe and Well Tolerated in Adults With Migraine and Cardiovascular Risk Factors: Results of a Multicenter, Long-Term, Open-Label Safety Study". You can view her abstract and others here: https://index.mirasmart.com/AAN2021/
